Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)

By José M. Ferro, P. Canhão, J. Stam, M. Bousser, F. Barinagarrementería. Stroke, 2004

2,306 citations recorded by the source corpus.

Subfields: Neurology, Otorhinolaryngology

View Paper: https://www.semanticscholar.org/paper/b592fa61a87f950301417aef7e7ae396326b85a4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. J. Stam
2. José M. Ferro

Citations in the corpus

• [Cerebral venous thrombosis]. (2013, background): “L'objectif du traitement antithrombotique est d’éviter la récidive (2-7 %) et la thrombose veineuse extracérébrale (5 %) [4].”
• European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology (2017, background): “In the prospective International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) study [36], diagnostic LP was performed in 224 patients (35.”
• Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011, neutral): “病因和发病机制:CVT的潜在危险因素 CVT 的诱因是多方面的。危险因素通常被归类 为获得性危险 ( 诸如手术、创伤、妊娠、围产期、 抗磷脂抗体综合征、癌症、外源性激素 ) 和遗传性 危险 ( 遗传性易栓症 )。 表 3 总结了促凝因素与 CVT 之间因果关系 [10,11] 的证据 ([12-55])。总结的证据涉及联系强度和一致性、”